TG THERAPEUTICS INC. - COMMON STOCK

TG Therapeutics to Participate in the Evercore HealthCONx Conference

29 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

25 ноя 2024 09:47:54 Источник NetDania Notify

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

21 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

14 ноя 2024 09:55:54 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

13 ноя 2024 11:43:19 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

12 ноя 2024 09:50:33 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

11 ноя 2024 09:45:41 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

08 ноя 2024 14:45:51 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

07 ноя 2024 10:01:11 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

06 ноя 2024 09:45:06 Источник NetDania Notify

TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance

04 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

01 ноя 2024 11:54:23 Источник NetDania Notify

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

01 ноя 2024 08:06:02 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

18 сен 2024 09:45:02 Источник NetDania Notify

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

18 сен 2024 07:15:00 Источник Nasdaq GlobeNewswire

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

18 сен 2024 07:00:03 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

17 сен 2024 12:04:03 Источник NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

16 сен 2024 14:44:05 Источник NetDania Notify

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

05 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

03 сен 2024 09:50:10 Источник NetDania Notify